Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changye Zou

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Bone Oncology|September 22, 2018
Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control studyHongyi Li, Xianbiao Xie, Junqiang Yin, et al.
Cancer Letters|September 25, 2021
Corrigendum to "Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway" [Canc. Lett. 342 (2014) 150-158]Zhiqiang Zhao, Man-Si Wu, Changye Zou, et al.
Cancer Letters|September 10, 2013
Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathwayZhiqiang Zhao, Man-Si Wu, Changye Zou, et al.
Cellular & Molecular Biology Letters|April 11, 2025
Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axisJunkai Chen, Hongbo Li, Qinglin Jin, et al.
Journal of Cancer|April 2, 2020
Clinical Significance of the Radiological Relationship between the Tumor and the main blood vessels in Enneking IIB Osteosarcoma of the extremitiesQinglin Jin, Xianbiao Xie, Hao Yao, et al.
Molecular Therapy. Nucleic Acids|March 11, 2019
miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β SignalingShuai Huang, Changye Zou, Yubo Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 16, 2025
LncDARS-AS1 Regulates ATP1A1 Stability and Enhances Na<sup>+</sup>/K<sup>+</sup> ATPase Activity to Promote Osteosarcoma MetastasisMingxian Xu, Jiatian Wei, Xiaoyu Feng, et al.
Molecular Therapy Oncolytics|May 6, 2020
Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB SignalingQingde Wa, Changye Zou, Zhuoyuan Lin, et al.
Molecular Therapy. Nucleic Acids|November 4, 2019
miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate CancerQingde Wa, Sheng Huang, Jincheng Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 InhibitorJiajun Zhang, Weihai Liu, Changye Zou, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Bone Oncology|September 22, 2018
Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control studyHongyi Li, Xianbiao Xie, Junqiang Yin, et al.
Cancer Letters|September 25, 2021
Corrigendum to "Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway" [Canc. Lett. 342 (2014) 150-158]Zhiqiang Zhao, Man-Si Wu, Changye Zou, et al.
Cancer Letters|September 10, 2013
Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathwayZhiqiang Zhao, Man-Si Wu, Changye Zou, et al.
Cellular & Molecular Biology Letters|April 11, 2025
Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axisJunkai Chen, Hongbo Li, Qinglin Jin, et al.
Journal of Cancer|April 2, 2020
Clinical Significance of the Radiological Relationship between the Tumor and the main blood vessels in Enneking IIB Osteosarcoma of the extremitiesQinglin Jin, Xianbiao Xie, Hao Yao, et al.
Molecular Therapy. Nucleic Acids|March 11, 2019
miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β SignalingShuai Huang, Changye Zou, Yubo Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 16, 2025
LncDARS-AS1 Regulates ATP1A1 Stability and Enhances Na<sup>+</sup>/K<sup>+</sup> ATPase Activity to Promote Osteosarcoma MetastasisMingxian Xu, Jiatian Wei, Xiaoyu Feng, et al.
Molecular Therapy Oncolytics|May 6, 2020
Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB SignalingQingde Wa, Changye Zou, Zhuoyuan Lin, et al.
Molecular Therapy. Nucleic Acids|November 4, 2019
miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate CancerQingde Wa, Sheng Huang, Jincheng Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 InhibitorJiajun Zhang, Weihai Liu, Changye Zou, et al.
Pageof 7